Rosenstock, J., Hollander, P., Chevalier, S., & Iranmanesh, A. (2008). SERENADE: The Study Evaluating Rimonabant Efficacy in Drug-Naive Diabetic Patients : Effects of monotherapy with rimonabant, the first selective CB(1) receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes. American Diabetes Association.
Citação norma ChicagoRosenstock, Julio, Priscilla Hollander, Soazig Chevalier, and Ali Iranmanesh. SERENADE: The Study Evaluating Rimonabant Efficacy in Drug-Naive Diabetic Patients : Effects of Monotherapy With Rimonabant, the First Selective CB(1) Receptor Antagonist, On Glycemic Control, Body Weight, and Lipid Profile in Drug-naive Type 2 Diabetes. American Diabetes Association, 2008.
Citação norma MLARosenstock, Julio, Priscilla Hollander, Soazig Chevalier, and Ali Iranmanesh. SERENADE: The Study Evaluating Rimonabant Efficacy in Drug-Naive Diabetic Patients : Effects of Monotherapy With Rimonabant, the First Selective CB(1) Receptor Antagonist, On Glycemic Control, Body Weight, and Lipid Profile in Drug-naive Type 2 Diabetes. American Diabetes Association, 2008.